Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
Medication labelALTUVIIIO is indicated for use in adults and pediatric patients with hemophilia A (congenital factor VIII deficiency) for: Routine…
Why this: Advisory · dailymed-prescription
ALTUVIIIO is indicated for use in adults and pediatric patients with hemophilia A (congenital factor VIII deficiency) for: Routine prophylaxis to reduce the frequency of bleeding episodes On-demand treatment and control of bleeding episodes Perioperative management of bleeding Limitation of Use ALTUVIIIO is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- brand_name
- efanesoctocog alfa, Sterile Water
- product_names
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl, efanesoctocog alfa, Sterile Water
- ndc
- 71104-978, 71104-979, 71104-981, 71104-982, 71104-983, 71104-984, 71104-978-01, 71104-985, 71104-985-08, 71104-035, 71104-035-01, 71104-979-01, 71104-986, 71104-986-08, 71104-981-01, 71104-988, 71104-988-08, 71104-982-01, 71104-989, 71104-989-08, 71104-983-01, 71104-990, 71104-990-08, 71104-984-01, 71104-991, 71104-991-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en